NCT02610192View on ClinicalTrials.gov

nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Patellofemoral Osteoarthritis
Interventions
DEVICE

nSTRIDE Autologous Protein Solution (APS) Kit

Intra-articular injection of APS

Trial Locations (1)

Unknown

AZ Monica, Deurne

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT02610192 - nSTRIDE APS in Females With Primary Patellofemoral Osteoarthritis | Biotech Hunter | Biotech Hunter